Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Ointment for Maintenance of Severe Facial Seborrheic Dermatitis
NCT02004860Phase 3Completed
- Sponsor
- Rouen University Hospital
- Start
- Jan 2014
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Tacrolimus Ointment 0.1% Iwaki in seborrheic dermatitis (SD), sponsored by Rouen University Hospital. Started Jan 2014; status: completed.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on NCT02004860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02004860.